Similar articles

• Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.

  Grob C, Bravo G, Walsh R. Grob C, et al. Arch Gen Psychiatry. 1990 Mar;47(3):288-9. doi: 10.1001/archpsyc.1990.01810150088014. Arch Gen Psychiatry. 1990. PMID: 1968330 Clinical Trial. No abstract available.
• New data intensify the agony over ecstasy.

  Barnes DM. Barnes DM. Science. 1988 Feb 19;239(4842):864-6. doi: 10.1126/science.2893452. Science. 1988. PMID: 2893452 No abstract available.
• ["Ecstasy" and "ice": the return of the amphetamines].

  Kaminer Y, Zemishlany Z. Kaminer Y, et al. Harefuah. 1991 Jun 16;120(12):727-9. Harefuah. 1991. PMID: 1683637 Review. Hebrew. No abstract available.
• Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.

  Schmidt CJ. Schmidt CJ. NIDA Res Monogr. 1989;94:179-95. NIDA Res Monogr. 1989. PMID: 2575224 Review. No abstract available.
• Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.

  Hekmatpanah CR, McKenna DJ, Peroutka SJ. Hekmatpanah CR, et al. Neurosci Lett. 1989 Sep 25;104(1-2):178-82. doi: 10.1016/0304-3940(89)90351-0. Neurosci Lett. 1989. PMID: 2573011